SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT Conectus Alsace SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10534
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT Conectus Alsace SAS (Conectus Alsace), a subsidiary of SATT Association, is a technology transfer service provider. The company offers services such as single entry point, well-defined research collaborations, technology transfers, accessible technology platforms, license approach, indexing, sensitization and training; management of IP rights and commercialization; investment, skills mapping, monitoring, contract management, platform management, and others. It provides accessible technology platforms for assessment of client analyses and evaluations. The company serves researchers and deal makers in health and life sciences, chemicals materials, engineering sciences, information and communication technology areas. Conectus Alsace is headquartered in Strasbourg, France.

SATT Conectus Alsace SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
Licensing Agreements 14
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS – Key Competitors 15
SATT Conectus Alsace SAS – Key Employees 16
SATT Conectus Alsace SAS – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lysogene Enters into Agreement with Institute of Genetics and Molecular and Cellular Biology (IGBMC) and SATT Conectus 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Conectus Alsace Enters into Co-Development Agreement with PEP-Therapy 13
SATT Conectus Alsace Enters into License Agreement with Syndivia 14
SATT Conectus Alsace SAS, Key Competitors 15
SATT Conectus Alsace SAS, Key Employees 16

List of Figures
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT Conectus Alsace SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TETRA Technologies Inc (TTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Foundation Radiology Group PC:製薬・医療:M&Aディール及び事業提携情報
    Summary Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems …
  • Australia and New Zealand Banking Group Ltd:企業のM&A・事業提携・投資動向
    Australia and New Zealand Banking Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Australia and New Zealand Banking Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Intermountain Rural Electric Association:企業の戦略的SWOT分析
    Intermountain Rural Electric Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Bayerische Landesbank:企業のM&A・事業提携・投資動向
    Bayerische Landesbank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayerische Landesbank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Secom Co., Ltd.:企業の戦略・SWOT・財務情報
    Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Brii Biosciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Brii Biosciences is an independent biotechnology company that focuses on developing and commercializing innovative medicines for infectious diseases, liver and lung diseases, and other chronic diseases. The company strives to advance breakthroughs in science and technology, and enable patien …
  • The Real Good Food Company plc:企業の戦略・SWOT・財務分析
    The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report Summary The Real Good Food Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) operates as a manufacturer of lead-acid storage batteries. The company operates through two sectors automotive battery and industrial battery sectors. Its automotive battery sector offers two-wheeler batteries, four-wheeler batteries and tubular batterie …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • CiCi Enterprises, LP:企業の戦略・SWOT・財務情報
    CiCi Enterprises, LP - Strategy, SWOT and Corporate Finance Report Summary CiCi Enterprises, LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Astute Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • Fauji Fertilizer Bin Qasim Ltd (FFBL):電力:M&Aディール及び事業提携情報
    Summary Fauji Fertilizer Bin Qasim Ltd (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural applicat …
  • Autogrill S.p.A.:企業の戦略・SWOT・財務情報
    Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Autogrill S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Marinus Pharmaceuticals Inc (MRNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Marinus Pharmaceuticals Inc (Marinus) is a clinical stage biopharmaceutical company that manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company’s pipeline product comprise ganaxolone is a CNS-selective GABAA mod …
  • Owens & Minor Inc (OMI):医療機器:M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆